Atlanta-based Emory Orthopedics & Spine Center's Ken Mautner, MD, is studying how three different stem cell therapies treat osteoarthritis, local news affiliate Fox 5 reports.
Biologics
A new study published in The Spine Journal examines long-term data on the risk for cancer associated with recombinant human bone morphogenetic protein use in spinal fusions.
A new study published in Spine examines 30- and 90-day readmission rates for spinal fusions.
Clinical stage regenerative medicine company, SpinalCyte, now features research studies on its website outlining the potential benefits of fibroblast technology.
Fort Collins, Colo.-based bioavailable cannabis solutions company, Geocann, hired Anthony Petraglia, MD, as CMO, and chairman of the Scientific and Medical Advisory Board.
Advertisement
Five spine surgeons discuss where they expect technology to evolve over the next half-decade.
A new study published in Spine examines bone graft substitutes for one- and two-level anterior cervical discectomy and fusion.
Vail, Colo.-based Steadman Clinic's Matthew Provencher, MD, received AlloSource's Dr. Steven Gitelis Inspiration Award to recognize his work using donated human tissue to help patients heal.
Marietta, Ga.-based biopharmaceutical company MiMedx has appointed Timothy Wright as its new CEO.
Orthopedic surgeon at San Diego-based Grossmont Hospital Scott A. Hacker, MD, treated the first four patients in the west coast with medical device company CartiHeal's Agili-C cartilage regeneration implant.